SAIL Trademark
Trademark Overview
On Monday, December 4, 2023, a trademark application was filed for SAIL with the United States Patent and Trademark Office. The USPTO has given the SAIL trademark a serial number of 98297806. The federal status of this trademark filing is OPPOSITION PENDING as of Wednesday, December 4, 2024. This trademark is owned by Sail Biomedicines, Inc.. The SAIL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases an...
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals
General Information
| Serial Number | 98297806 |
| Word Mark | SAIL |
| Filing Date | Monday, December 4, 2023 |
| Status | 774 - OPPOSITION PENDING |
| Status Date | Wednesday, December 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 5, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism |
| Goods and Services | Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 27, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 25, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Sail Biomedicines, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Party Name | Sail Biomedicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
Trademark Events
| Event Date | Event Description |
| Monday, December 4, 2023 | NEW APPLICATION ENTERED |
| Wednesday, February 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 2, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 2, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 2, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, September 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 16, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 5, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, December 4, 2024 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Wednesday, December 4, 2024 | OPPOSITION INSTITUTED NO. 999999 |
